Glomerulopathy in the KK.Cg- Ay/J mouse reflects the pathology of diabetic nephropathy

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  O'Brien, Stephen P ^a   Smith, Mandy ^a   Ling, Hong ^a   Phillips, Lucy ^a   Weber, William ^a   Lydon, John ^a   Maloney, Colleen ^a   Ledbetter, Steven ^a   Arbeeny, Cynthia ^a   Wawersik, Stefan ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHOLESTEROL; FIBRONECTIN; FIBRONECTIN 1; GELATINASE B; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LEPTIN; NEPHRIN; NITROGEN; PODOCIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CELL DENSITY; CELL EXPANSION; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MODEL; DISEASE SEVERITY; FAT INTAKE; FEMALE; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; KIDNEY HYPERTROPHY; KK CG AY J MOUSE; MACROPHAGE; MESANGIUM CELL; MOUSE; MOUSE STRAIN; NEPHRECTOMY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; GLOMERULUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MICE; PODOCYTES;

EID: 84878161664     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/498925     Document Type: Article

References (51)

1. Collins A. J., Foley R. N., Chavers B., US renal data system 2011 Annual data report. American Journal of Kidney Diseases 2012 59 1 e1 e26 10.1053/j.ajkd.2011.10.014
2. Whaley-Connell A., Sowers J. R., McCullough P. A., Roberts T., McFarlane S. I., Chen S. C., Li S., Wang C., Collins A. J., Bakris G. L., Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES). American Journal of Kidney Diseases 2009 53 4 S11 S21 2-s2.0-61749103126 10.1053/j.ajkd.2009.01.004
3. Fioretto P., Mauer M., Histopathology of diabetic nephropathy. Seminars in Nephrology 2007 27 2 195 207 2-s2.0-34047251834 10.1016/j.semnephrol.2007.01. 012 (Pubitemid 46550314)
4. Tervaert T. W. C., Mooyaart A. L., Amann K., Cohen A. H., TerenceCook H., Drachenberg C. B., Ferrario F., Fogo A. B., Haas M., De Heer E., Joh K., Noë L L. H., Radhakrishnan J., Seshan S. V., Bajema I. M., Bruijn J. A., Pathologic classification of diabetic nephropathy. Journal of the American Society of Nephrology 2010 21 4 556 563 2-s2.0-77950601556 10.1681/ASN. 2010010010
5. Reddy G. R., Kotlyarevska K., Ransom R. F., Menon R. K., The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Current Opinion in Nephrology and Hypertension 2008 17 1 32 36 2-s2.0-37349120735 10.1097/MNH.0b013e3282f2904d (Pubitemid 350295194)
6. Makino H., Miyamoto Y., Sawai K., Mori K., Mukoyama M., Nakao K., Yoshimasa Y., Suga S. I., Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006 55 10 2747 2756 2-s2.0-33750866706 10.2337/db05-1683 (Pubitemid 44923673)
7. Toyoda M., Najafian B., Kim Y., Caramori M. L., Mauer M., Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007 56 8 2155 2160 2-s2.0-34547611903 10.2337/db07-0019 (Pubitemid 47195834)
8. Pagtalunan M. E., Miller P. L., Jumping-Eagle S., Nelson R. G., Myers B. D., Rennke H. G., Coplon N. S., Sun L., Meyer T. W., Podocyte loss and progressive glomerular injury in type II diabetes. Journal of Clinical Investigation 1997 99 2 342 348 2-s2.0-0031029379 (Pubitemid 27053474)
9. White K. E., Bilous R. W., On Behalf of the Diabiopsies Study Group, Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrology Dialysis Transplantation 2004 19 6 1437 1440 10.1093/ndt/gfh129 (Pubitemid 38786736)
10. Breyer M. D., Böttinger E., Brosius F. C., Coffman T. M., Harris R. C., Heilig C. W., Sharma K., Mouse models of diabetic nephropathy. Journal of the American Society of Nephrology 2005 16 1 27 45 2-s2.0-21644463370 10.1681/ASN.2004080648 (Pubitemid 43073154)
11. Brosius F. C., Alpers C. E., Bottinger E. P., Breyer M. D., Coffman T. M., Gurley S. B., Harris R. C., Kakoki M., Kretzler M., Leiter E. H., Levi M., McIndoe R. A., Sharma K., Smithies O., Susztak K., Takahashi N., Takahashi T., Mouse models of diabetic nephropathy. Journal of the American Society of Nephrology 2009 20 12 2503 2512 2-s2.0-72049119396 10.1681/ASN.2009070721
12. Rüster C., Wolf G., Models of diabetic nephropathy. Drug Discovery Today 2010 7 1-2 35 41 2-s2.0-78650513225 10.1016/j.ddmod.2010.08.001
13. Soler M. J., Riera M., Batlle D., New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Experimental Diabetes Research 2012 2012 9 218917 10.1155/2012/218917
14. Breyer M. D., Progress in progression? Journal of the American Society of Nephrology 2010 21 9 1414 1416 2-s2.0-77956514676 10.1681/ASN.2010070744
15. Schlöndorff D., Choosing the right mouse model for diabetic nephropathy. Kidney International 2010 77 9 749 750 2-s2.0-77951053907 10.1038/ki.2009.545
16. Diani A. R., Sawada G. A., Hannah B. A., Jodelis K. S., Connell M. A., Connell C. L., Vidmar T. J., Wyse B. M., Analysis of pancreatic islet cells and hormone content in the spontaneously diabetic KK A y mouse by morphometry, immunocytochemistry and radioimmunoassay. Virchows Archiv 1987 412 1 53 61 2-s2.0-0023615867 (Pubitemid 17159640)
17. Chakraborty G., Thumpayil S., Lafontant D. E., Woubneh W., Toney J. H., Age dependence of glucose tolerance in adult KK-A y mice, a model of non-insulin dependent diabetes mellitus. Lab Animal 2009 38 11 364 368 2-s2.0-70350302229 10.1038/laban1109-364
18. Yamazaki T., Tanimoto M., Gohda T., Ohara I., Hagiwara S., Murakoshi M., Matsumoto M., Kaneko S., Aoki T., Toyoda H., Ishikawa Y., Funabiki K., Horikoshi S., Tomino Y., Combination effects of enalapril and losartan on lipid peroxidation in the kidneys of KK- A y /Ta mice. Nephron 2009 113 2 e66 e76 2-s2.0-67650501025 10.1159/000228714
19. Diani A. R., Sawada G. A., Zhang N. Y., Wyse B. M., Connell C. L., Vidmar T. J., Connell M. A., The KKA(y) mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 1987 24 6 297 303 2-s2.0-0023525956 (Pubitemid 18013164)
20. Okazaki M., Saito Y., Udaka Y., Maruyama M., Murakami H., Ota S., Kikuchi T., Oguchi K., Diabetic nephropathy in KK and KK- A y mice. Experimental Animals 2002 51 2 191 196 2-s2.0-0036547834 10.1538/expanim.51.191 (Pubitemid 135695677)
21. Ito T., Tanimoto M., Yamada K., Kaneko S., Matsumoto M., Obayashi K., Hagiwara S., Murakoshi M., Aoki T., Wakabayashi M., Gohda T., Funabiki K., Maeda K., Horikoshi S., Tomino Y., Glomerular changes in the KK- A y /Ta mouse: a possible model for human type 2 diabetic nephropathy. Nephrology 2006 11 1 29 35 2-s2.0-33645361420 10.1111/j.1440-1797.2006.00543.x
22. Shiuchi T., Cui T. X., Wu L., Nakagami H., Takeda-Matsubara Y., Iwai M., Horiuchi M., ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension 2002 40 3 329 334 2-s2.0-0036711810 10.1161/01.HYP.0000028979.98877.0C (Pubitemid 35006719)
23. Sasaki M., Uehara S., Ohta H., Taguchi K., Kemi M., Nishikibe M., Matsumoto H., Losartan ameliorates progression of glomerular structural changes in diabetic KK A y mice. Life Sciences 2004 75 7 869 880 2-s2.0-2942536127 10.1016/j.lfs.2004.01.022 (Pubitemid 38737423)
24. Matsumoto M., Tanimoto M., Gohda T., Aoki T., Murakoshi M., Yamada K., Yamazaki T., Kaneko S., Horikoshi S., Tomino Y., Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK- A y /Ta mice. Metabolism 2008 57 5 691 697 2-s2.0-42949130547 10.1016/j.metabol.2008.01.007 (Pubitemid 351608231)
25. Ohara I., Tanimoto M., Gohda T., Yamazaki T., Hagiwara S., Murakoshi M., Aoki T., Toyoda H., Ishikawa Y., Funabiki K., Horikoshi S., Tomino Y., Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D3 in type 2 diabetic nephropathy in KK-A y/Ta mice. Nephron 2011 117 4 e124 e132 2-s2.0-77957780608 10.1159/000320284
26. Fried L. F., Duckworth W., Zhang J. H., O'Connor T., Brophy M., Emanuele N., Huang G. D., McCullough P. A., Palevsky P. M., Seliger S., Warren S. R., Peduzzi P., Design of combination angiotensin receptor blocker and angiotensin- converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). Clinical Journal of the American Society of Nephrology 2009 4 2 361 368 2-s2.0-66849128220 10.2215/CJN.03350708
27. Parving H.-H., Brenner B. M., McMurray J. J. V., De Zeeuw D., Haffner S. M., Solomon S. D., Chaturvedi N., Ghadanfar M., Weissbach N., Xiang Z., Armbrecht J., Pfeffer M. A., Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrology Dialysis Transplantation 2009 24 5 1663 1671 2-s2.0-65249182083 10.1093/ndt/gfn721
28. Suto J. I., Matsuura S., Imamura K., Yamanaka H., Sekikawa K., Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-A(y) mice. European Journal of Endocrinology 1998 139 6 654 661 2-s2.0-0032420530 10.1530/eje.0.1390654 (Pubitemid 29030406)
29. Ninomiya H., Inomata T., Ogihara K., Obstructive uropathy and hydronephrosis in male KK- A y mice: a report of cases. Journal of Veterinary Medical Science 1999 61 1 53 57 2-s2.0-0032605691 (Pubitemid 129581164)
30. Nakamura M., Yamada K., Studies on a diabetic (KK) strain of the mouse. Diabetologia 1967 3 2 212 221 2-s2.0-0014076251 10.1007/BF01222198
31. Becker B., Kronenberg F., Kielstein J. T., Haller H., Morath C., Ritz E., Fliser D., Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. Journal of the American Society of Nephrology 2005 16 4 1091 1098 2-s2.0-21344446701 10.1681/ASN.2004090742 (Pubitemid 41710320)
32. Ha H., Oh E. Y., Lee H. B., The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nature Reviews Nephrology 2009 5 4 203 211 2-s2.0-67049167761 10.1038/nrneph.2009.15
33. Chang J. H., Paik S. Y., Mao L., Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. PLoS ONE 7 4 e33942 10. 1371/journal.pone. 0033942
34. Wang Y., Zhao S., Loyd S., Groome L. J., Increased urinary excretion of nephrin, podocalyxin, and betaig-h3 in women with preeclampsia. American Journal of Physiology 2012 302 9 F1084 F1089 10.1152/ajprenal.00597.2011
35. Vaidya V. S., Ramirez V., Ichimura T., Bobadilla N. A., Bonventre J. V., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. American Journal of Physiology 2006 290 2 F517 F529 2-s2.0-33644870877 10.1152/ajprenal.00291.2005 (Pubitemid 43725006)
36. Sabbisetti V. S., Ito K., Wang C., Novel assays for detection of urinary Kim-1 in mouse models of kidney injury. Toxicological Sciences 2013 131 1 13 25 10.1093/toxsci/kfs268
37. Ronco P., Proteinuria: is it all in the foot? Journal of Clinical Investigation 2007 117 8 2079 2082 2-s2.0-34547678397 10.1172/JCI32966 (Pubitemid 47219549)
38. D'Agati V. D., Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney International 2008 73 4 399 406 2-s2.0-38749153591 10.1038/sj.ki.5002655 (Pubitemid 351186280)
39. Lee F. T. H., Cao Z., Long D. M., Panagiotopoulos S., Jerums G., Cooper M. E., Forbes J. M., Interactions between angiotensin II and NF- B-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. Journal of the American Society of Nephrology 2004 15 8 2139 2151 2-s2.0-3543069402 10.1097/01.ASN.0000135055.61833.A8 (Pubitemid 39031352)
40. Nagata M., Scharer K., Kriz W., Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney International 1992 42 1 136 147 2-s2.0-0026763030
41. Turner J. M., Bauer C., Abramowitz M. K., Melamed M. L., Hostetter T. H., Treatment of chronic kidney disease. Kidney International 2012 81 351 362 10.1038/ki.2011.380
42. Chavez J. A., Summers S. A., Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochimica et Biophysica Acta 2010 1801 3 252 265 2-s2.0-76049095119 10.1016/j.bbalip.2009.09.015
43. Jensen M. N., Ritskes-Hoitinga M., How isoflavone levels in common rodent diets can interfere with the value of animal models and with experimental results. Laboratory Animals 2007 41 1 1 18 2-s2.0-33846590593 10.1258/002367707779399428 (Pubitemid 46174423)
44. Setchell K. D. R., Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 1998 68 supplement 6 1333S 1346S 2-s2.0-0031741906 (Pubitemid 28550909)
45. Sharma K., RamachandraRao S., Qiu G., Usui H. K., Zhu Y., Dunn S. R., Ouedraogo R., Hough K., McCue P., Chan L., Falkner B., Goldstein B. J., Adiponectin regulates albuminuria and podocyte function in mice. Journal of Clinical Investigation 2008 118 5 1645 1656 2-s2.0-43049095682 10.1172/JCI32691 (Pubitemid 351632369)
46. Eddy A. A., Fogo A. B., Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. Journal of the American Society of Nephrology 2006 17 11 2999 3012 2-s2.0-33750716519 10.1681/ASN.2006050503 (Pubitemid 44707760)
47. Goldberg R. B., Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3171 3182 2-s2.0-69949093803 10.1210/jc.2008-2534
48. Ng D. P. K., Tai B. C., Tan E., Leong H., Nurbaya S., Lim X. L., Chia K. S., Wong C. S., Lim W. Y., Holthöfer H., Nephrinuria associates with multiple renal traits in type 2 diabetes. Nephrology Dialysis Transplantation 2011 26 8 2508 2514 2-s2.0-79961050055 10.1093/ndt/gfq738
49. Saleh M. A., Boesen E. I., Pollock J. S., Savin V. J., Pollock D. M., Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia 2011 54 4 979 988 2-s2.0-79953828524 10.1007/s00125-010-2021-4
50. Group CKDW, Department of Defense (DoD), VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care. Version 2.0. Veterans Health Administration (VHA) DoVAV 2008 Washingon DC, USA Veterans Health Administration and Department of Defense
51. National Kidney Foundation, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002 39 2, supplement 1 S1 S266